(Reuters) -Paracetamol maker Granules India reported a 34% jump in its second-quarter profit on Thursday, driven by strong demand in its key European and North American markets.

Consolidated profit rose to 1.31 billion rupees (nearly $15 million) in the quarter ended September 30 from 972.3 million rupees a year earlier.

Granules, which generates about two-thirds of its revenue from North America and 19% from Europe, posted a 34.2% rise in revenue from operations to 12.97 billion rupees.

Sales in North America jumped 30%, while those in Europe surged 66%.

For further earnings highlights, click.

KEY CONTEXT

Granules India, which has a 30% share of the global paracetamol market, supplies the drug both as an active pharmaceutical ingredient (API) and in finished dosage form across Europ

See Full Page